Pathology managed service planned by Gloucestershire Hospitals
- Gloucestershire Hospitals NHS Foundation Trust
- 3 July 2028 to 3 July 2040
Gloucestershire Hospitals NHS Foundation Trust plans to buy a pathology managed service and has asked suppliers for their views before it tenders. The contract would cover the analysers, automation and point-of-care devices in its laboratories, with their upkeep, reagents, software and staff training.
Phase 1 covers the labs the trust runs at Gloucestershire Royal Hospital and Cheltenham General Hospital. Phase 2 follows a move into a new-build pathology hub, whose site is not yet chosen.
Blood Sciences, Infection Sciences and Cellular Pathology are in scope, plus enabling works to get lab space ready. The trust expects Blood Sciences to have a lead provider, with further lots for the other disciplines, and wants views on that split. Responses are due by 4 December 2026. The service is estimated at £150m and could run to July 2042 with extensions.
Due in 12 days· 4 Dec 2026
- What
- Pathology managed services and blood sciences analysers
- Estimated value
- £150m
- How it will be bought
- Not published
- Responses due
- 4 Dec 2026
- Contract dates
- Jul 2028 to Jul 2040
- Option to Jul 2042